APS
29th APS Annual Convention · 2017
Effects of Galantamine on Laboratory Choice Task in Daily Smokers
Session: Poster Session XI
Authors
- Robert MacLeanPresenting Author
VA Connecticut Healthcare System - West Haven - Robert MacLeanPresenting Author
Yale University - Mehmet Sofuoglu
VA Connecticut Healthcare System - West Haven - Mehmet Sofuoglu
Yale University - Andrew Waters
Uniformed Service University of the Health Sciences
Abstract
Galantamine (an Acetylcholinesterase inhibitor) is a promising new treatment for tobacco addiction that is believed to attenuate the acute effects of nicotine. Results of a cigarette choice task in daily smokers reveal Galantamine treatment group, compared to placebo, chose monetary reward over opportunity to smoke more frequently.
Substance Abuse